We serve Chemical Name:[2-Fluoro-5-(trifluoromethoxy)phenyl]boronic acid CAS:881402-22-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:[2-Fluoro-5-(trifluoromethoxy)phenyl]boronic acid
CAS.NO:881402-22-8
Synonyms:[2-Fluoro-5-(trifluoromethoxy)phenyl]boronic acid;Boronic acid, B-[2-fluoro-5-(trifluoromethoxy)phenyl]-
Molecular Formula:C7H5BF4O3
Molecular Weight:223.917
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:279.9±50.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.447
PSA:49.69000
Exact Mass:224.026794
LogP:2.67
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like [2-Fluoro-5-(trifluoromethoxy)phenyl]boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Boronic acid, B-[2-fluoro-5-(trifluoromethoxy)phenyl]- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Boronic acid, B-[2-fluoro-5-(trifluoromethoxy)phenyl]- Use and application,Boronic acid, B-[2-fluoro-5-(trifluoromethoxy)phenyl]- technical grade,usp/ep/jp grade.
Related News: In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China. [2-Fluoro-5-(trifluoromethoxy)phenyl]boronic acid manufacturer In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. [2-Fluoro-5-(trifluoromethoxy)phenyl]boronic acid supplier In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. [2-Fluoro-5-(trifluoromethoxy)phenyl]boronic acid vendor In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. [2-Fluoro-5-(trifluoromethoxy)phenyl]boronic acid factory In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.